Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2022-10-11 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to the reporting of lost share certificates. The content is an official notification to take the information on record, signed by the Company Secretary. There is no financial data, no report attached or referenced as being published, and no mention of voting results or management changes. This fits the category of a regulatory announcement related to compliance and disclosure obligations but does not fit into categories like Annual Report, Earnings Release, or Share Issue. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-10-11 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss reporting. The content is a notification to the exchanges to take the information on record. There is no financial data, no report attached or referenced, no management discussion, no voting results, no capital changes, or other report types. This is a regulatory announcement related to share certificate loss, which fits best under Regulatory Filings (RNS) as it is a compliance disclosure that does not fit other specific categories.
2022-10-06 English
Revised: Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication ....
Regulatory Filings Classification · 95% confidence The document is a corporate announcement addressed to stock exchanges regarding the loss of share certificates, made pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements). It is a notification to the exchange to take the information on record. The document is short (2134 characters) and does not contain financial data, management discussion, or any report content. It is not an annual report, earnings release, or any financial report. It is a regulatory announcement about share certificate loss, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-10-06 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent for the quarter ended 30th September 2022. It is a compliance certificate submitted to stock exchanges, not a full financial report or detailed filing. The document is short (1418 characters) and serves as an attestation or confirmation letter rather than containing substantive financial data or analysis. Therefore, it fits the criteria for a Regulatory Filing (RNS) rather than an Interim Report or any other detailed report type.
2022-10-06 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, citing compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations. It provides details of the lost certificates and requests the information be taken on record. There is no financial data, report, or presentation content. This is a regulatory announcement related to share certificate loss, which does not fit into financial reports or other specific categories. Therefore, it falls under Regulatory Filings (RNS), which is the fallback category for miscellaneous compliance and regulatory announcements.
2022-10-06 English
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 30th September 2022 under Regulation ....
Regulatory Filings
2022-10-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.